These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2787809)

  • 1. The effects of flurbiprofen, aspirin, cimetidine, and antacids on the gastric and duodenal mucosa of normal volunteers. An endoscopic and photographic study.
    Friedman H; Seckman CE; Schwartz JH; Lanza FL; Royer GL; Stubbs CM
    J Clin Pharmacol; 1989 Jun; 29(6):559-62. PubMed ID: 2787809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flurbiprofen and aspirin on the gastric and duodenal mucosa. An endoscopic comparison.
    Lanza FL; Royer GL; Nelson RS; Seckman CE; Schwartz JH; Rack MF; Gernaat CM
    Am J Med; 1986 Mar; 80(3A):31-5. PubMed ID: 3963025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS
    N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
    Stiel D; Ellard KT; Hills LJ; Brooks PM
    Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
    Müller P; Simon B
    Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute damage of gastroduodenal mucosa by acetylsalicylic acid: no prolonged protection by antacids.
    Berstad K; Haram EM; Weberg R; Berstad A
    Aliment Pharmacol Ther; 1989 Dec; 3(6):585-90. PubMed ID: 2518872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. An endoscopic comparison.
    Scheiman JM; Behler EM; Berardi RR; Elta GH
    Dig Dis Sci; 1989 Feb; 34(2):229-32. PubMed ID: 2914543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
    Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic evaluation of the comparative effects of acetylsalicylic acid and choline magnesium trisalicylate on human gastric and duodenal mucosa.
    Kilander A; Dotevall G
    Br J Rheumatol; 1983 Feb; 22(1):36-40. PubMed ID: 6337663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy.
    Berkowitz JM; Rogenes PR; Sharp JT; Warner CW
    Arch Intern Med; 1987 Dec; 147(12):2137-9. PubMed ID: 3689065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans.
    Scheiman JM; Elta GH
    Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.
    Cryer B; Feldman M
    Gastroenterology; 1999 Jul; 117(1):17-25. PubMed ID: 10381905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit.
    Peura DA; Johnson LF
    Ann Intern Med; 1985 Aug; 103(2):173-7. PubMed ID: 3874573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic study of gastro-intestinal injury with non-steroidal anti-inflammatory drugs.
    Vakil BJ; Shah PN; Dalal NJ; Wagholikar UN; Pispati PK
    Curr Med Res Opin; 1977; 5(1):38-42. PubMed ID: 334472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of gastro-intestinal blood loss in volunteers treated with non-steroidal anti-inflammatory agents.
    Vakil BJ; Kulkarni RD; Kulkarni VN; Mehta DJ; Gharpure MB; Pispati PK
    Curr Med Res Opin; 1977; 5(1):32-7. PubMed ID: 334471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
    Hoftiezer JW; O'Laughlin JC; Ivey KJ
    Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease.
    Jönsson KA; Ström M; Bodemar G; Norrby K
    Scand J Gastroenterol; 1988 May; 23(4):433-41. PubMed ID: 3289111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroduodenal mucosal injuries by aspirine. Management of the risks].
    Martínez M JD; Molano V JC; Henao R SC
    Rev Gastroenterol Peru; 2016; 36(2):129-34. PubMed ID: 27409089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.